Hazardous Drug Sample Analysis

2026-11-03

********************************************************** UPDATE - AMENDMENT # 1 *** The Purpose of this Amendment is to Provide Answers to Questions . QUESTION # 1 - The workload breakdown in the PWS ( page 8 ) is structured simply by the number of drugs per sample batch , can you provide the specific drug types for each ? ANSWER # 1 - A .) The PWS lists 6 possible Hazardous Drugs that a client could request . These are the only 6 requested at this time in any combination . They are : 5 - Fluorouracil , Methotrexate , Ifosfamide , Cyclophosphamide Monohydrate , Doxorubicin Hydrochloride , and Paclitaxel . B .) For Example , when a client wants " 2 " drugs reported , it could be a combination of any 2 of the above . One Client could request Methotrexate and Paclitaxel . Another Client could request 5 - Fluorouracil and Ifosfamide . Both are only requesting " 2 " but the actual drugs are net set . Historically , 17 clients only wanted 1 drug reported for each sample . ( each one though could have been unique ) QUESTION # 2 - Is the Government or the Contractor to supply the wipes ? ANSWER # 2 - The Government will supply the wipes . QUESTION # 3 - Please confirm that the government will be taking the samples and not the Contractor ' s technicians ( i . e ., the contract is ' lab only '). ANSWER # 3 - The client ( government ) will collect the samples ; nothing would be collected by the contract lab .******************************************************** As part of the DCPH - A mission , the Lab Sciences ( LS ) Directorate requires the analysis of wipe / swab samples for the presence of hazardous drugs in support of pharmacies and Military Treatment Facilities ( MTFs ) within the Department of War ( DoW ). This analysis is mandated for the MTFs using Chemotherapy drugs to ensure their cleaning procedures are effective to ensure safety of the MTF staff and to avoid cross - contamination . The directives that mandate this semi - annual testing requirement are United Stated Pharmacopiea ( USP ) 800 : Handling Hazardous Drugs and Technical Bulletin - Medical ( TB - MED ) 515 : Occupational Health and Indutrial Hygiene Guidance for the Management , Use and Disposal of Hazardous Drugs . There is no acceptable level of occupational exposure to Hazardous Drugs . The LS Directorate of the DCPH - A is the only government laboratory to perform this hazardous drugs analysis as required . While LS does have the analytical capability to perform hazardous drugs analyses , as a sole source for this effort , there is a need to have back - up laboratory capability for instances of instrument down - time or over - capacity situations . Objectives for this Requirement are as follows : The Contractor shall perform analysis on wipe / swab samples provided by the Government for Hazardous Drugs contamination . The Contractor shall perform the sample analysis within the stated turnaround time ( TAT ) identified in the Outsource Document and identified in the PWS . The Contractor shall provide Quality wipe / swab analysis for various hazardous drugs as identified in this PWS in accordance with an accredited methodology . The Contractor shall dispose of unused samples as prescribed by their quality manual / Standing Operating Procedures and return Government shipping containers . The Contractor shall supply sampling media upon request . The Contractor shall pay liquidated damages for late or deficient reporting as detailed in Section 5 . of the PWS . QUESTIONSare due by20 April 2026 by 1pm Eastern Standard Time ( EST ) QUOTATIONSare due by24 April 2026 by 11am EST . See the Performance Work Statement ( PWS ) for complete information regarding this effort .

Maryland

2026-05-02